FLGT Q4 2023 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$71M+4.1% YoY

Gross Profit

$25M35.8% margin

Operating Income

-$151M-214.3% margin

Net Income

-$128M-181.8% margin

EPS (Diluted)

$-4.30

QoQ Revenue Growth

-16.7%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$12M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$102M

Stockholders' Equity

$1.1B

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$68M	+4.1%
Gross Profit	$25M	$13M	+94.3%
Operating Income	-$151M	-$37M	-313.4%
Net Income	-$128M	-$24M	-437.7%

Geographic Segments

UNITED STATES

$65M92%

Non-US

$6M8%